Matthew Harrison
Stock Analyst at Morgan Stanley
(3.39)
# 999
Out of 4,984 analysts
699
Total ratings
48.24%
Success rate
3.56%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $13.06 | +129.71% | 13 | Aug 18, 2025 | |
| INSM Insmed | Downgrades: Equal-Weight | $112 → $126 | $144.78 | -12.97% | 19 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $34.47 | +140.79% | 13 | Aug 12, 2025 | |
| IOBT IO Biotech | Maintains: Overweight | $6 → $4 | $1.71 | +133.92% | 6 | Aug 12, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $460 → $439 | $387.15 | +13.39% | 41 | Aug 5, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $754 → $761 | $585.50 | +29.97% | 55 | Aug 4, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $146 → $144 | $144.87 | -0.60% | 54 | Aug 1, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $700 → $766 | $734.35 | +4.31% | 25 | Aug 1, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Equal-Weight | $15 → $20 | $17.05 | +17.30% | 38 | Jul 29, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $97 → $96 | $54.37 | +76.57% | 22 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $184.59 | +16.47% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $112.26 | +20.26% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $2.91 | +106.19% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $39 → $32 | $25.00 | +28.00% | 25 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.22 | +309.84% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $169.37 | +5.10% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $35.89 | +56.03% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $32.43 | +69.60% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.95 | +1.69% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $21.85 | -49.66% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.42 | +463.38% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.72 | +157.35% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $24.08 | +41.20% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $28.08 | +13.96% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $4.65 | +308.60% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.15 | -13.04% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.38 | -48.40% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $7.32 | +9.29% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.19 | +36.69% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.04 | +327.63% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $12.31 | +549.88% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.37 | +1,017.32% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $98.15 | +120.07% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.25 | +53.85% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.04 | +145.10% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $220.81 | -17.58% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $9.21 | -2.28% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $42.18 | -5.17% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $274.71 | +2.65% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $451.73 | -53.51% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.05 | +116.22% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $177.20 | -2.37% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $28.71 | +317.97% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $14.70 | +906.80% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $81.14 | +1.06% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $46.15 | +43.01% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $2.90 | +1,244.83% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $35.64 | +29.07% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $10.45 | +234.93% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $760.13 | -63.82% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.83 | +571.38% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $9.03 | +586.60% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.54 | -1.65% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $84.80 | -2.12% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $47.56 | -78.97% | 4 | Sep 10, 2018 |
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $13.06
Upside: +129.71%
Insmed
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $144.78
Upside: -12.97%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $34.47
Upside: +140.79%
IO Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $1.71
Upside: +133.92%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $387.15
Upside: +13.39%
Regeneron Pharmaceuticals
Aug 4, 2025
Maintains: Overweight
Price Target: $754 → $761
Current: $585.50
Upside: +29.97%
Biogen
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $146 → $144
Current: $144.87
Upside: -0.60%
argenx SE
Aug 1, 2025
Maintains: Overweight
Price Target: $700 → $766
Current: $734.35
Upside: +4.31%
Sarepta Therapeutics
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $17.05
Upside: +17.30%
BioMarin Pharmaceutical
Jul 22, 2025
Maintains: Overweight
Price Target: $97 → $96
Current: $54.37
Upside: +76.57%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $184.59
Upside: +16.47%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $112.26
Upside: +20.26%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $2.91
Upside: +106.19%
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $25.00
Upside: +28.00%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.22
Upside: +309.84%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $169.37
Upside: +5.10%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $35.89
Upside: +56.03%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $32.43
Upside: +69.60%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.95
Upside: +1.69%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $21.85
Upside: -49.66%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.42
Upside: +463.38%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.72
Upside: +157.35%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $24.08
Upside: +41.20%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $28.08
Upside: +13.96%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $4.65
Upside: +308.60%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.15
Upside: -13.04%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.38
Upside: -48.40%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $7.32
Upside: +9.29%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.19
Upside: +36.69%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.04
Upside: +327.63%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $12.31
Upside: +549.88%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.37
Upside: +1,017.32%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $98.15
Upside: +120.07%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.25
Upside: +53.85%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.04
Upside: +145.10%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $220.81
Upside: -17.58%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $9.21
Upside: -2.28%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $42.18
Upside: -5.17%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $274.71
Upside: +2.65%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $451.73
Upside: -53.51%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.05
Upside: +116.22%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $177.20
Upside: -2.37%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $28.71
Upside: +317.97%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $14.70
Upside: +906.80%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $81.14
Upside: +1.06%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $46.15
Upside: +43.01%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $2.90
Upside: +1,244.83%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $35.64
Upside: +29.07%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $10.45
Upside: +234.93%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $760.13
Upside: -63.82%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.83
Upside: +571.38%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $9.03
Upside: +586.60%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.54
Upside: -1.65%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $84.80
Upside: -2.12%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $47.56
Upside: -78.97%